Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-16-022163
Filing Date
2016-04-08
Accepted
2016-04-08 09:40:03
Documents
1
Effectiveness Date
2016-04-08

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-16-022163.paper CERTNAS 294
  Scanned paper document scanned.pdf   33629
  Complete submission text file 9999999997-16-022163.txt   1301
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-37355 | Film No.: 16004161
SIC: 2834 Pharmaceutical Preparations